Publications by authors named "Amy L Batoosingh"

Claim this Profile
A
Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits: response to authors.
Joan-En Chang-Lin, Amy L Batoosingh, David A Hollander, Rhett M Schiffman, Diane D-S Tang-Liu

Clin Ophthalmol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety and efficacy of bimatoprost/timolol fixed combination: a 1-year double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertension.
Richard A Lewis, Ronald L Gross, Kenneth N Sall, Rhett M Schiffman, Ching Chi Liu, Amy L Batoosingh

J Glaucoma· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twelve-month, randomized, controlled trial of bimatoprost 0.01%, 0.0125%, and 0.03% in patients with glaucoma or ocular hypertension.
L Jay Katz, John S Cohen, Amy L Batoosingh, Carlos Felix, Vincent Shu

Am J Ophthalmol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of brimonidine purite 0.1% and brimonidine purite 0.15%: a meta-analysis of two phase 3 studies.
Louis B Cantor, Ching-Chi Liu, Amy L Batoosingh, David A Hollander

Curr Med Res Opin· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brimonidine-purite 0.1% versus brimonidine-purite 0.15% twice daily in glaucoma or ocular hypertension: a 12-month randomized trial.
Louis B Cantor, Eleonora Safyan, Ching-Chi Liu, Amy L Batoosingh

Curr Med Res Opin· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bimatoprost/timolol fixed combination: a 3-month double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertension.
James D Brandt, Louis B Cantor, L Jay Katz, Amy L Batoosingh, Connie Chou

J Glaucoma· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial.
Mark B Sherwood, E Randy Craven, Connie Chou, Harvey B DuBiner, Amy L Batoosingh

Arch Ophthalmol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure.
Neil Choplin, Paula Bernstein, Amy L Batoosingh, Scott M Whitcup,

Surv Ophthalmol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.
Robert S Noecker, Monte S Dirks, Neil T Choplin, Paula Bernstein, Amy L Batoosingh

Am J Ophthalmol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis